Skip to content

What kind of change are WE talking about?

In this third blog in our series about Delivering Change we provide a brief overview of what CHC means when we talk about change.

 

‘Change’ has become a buzzword in our industry but more often than not, this ‘change’ only ever relates to behaviour change – changing the prescribing habits of healthcare professionals or changing people’s engagement in their own health. At CHC, we wanted to take this one step further and be more specific about ‘change’. Read more

Building on Theories of Change

 

In our recent press release announcing the launch of our Delivering ChangeTM planning model, we mentioned how we were inspired by Theories of Change.

In this 3 minute blog we’ll provide a some background on theories of change; what they are, how they work and how we’ve built on this to create CHC’s unique model.

Read more

What’s this Delivering Change model all about?

On 1st August we launched our new Delivering ChangeTM planning model and in this short blog we wanted to outline the two key reasons why.

  1. We’re serious about focusing our work around real, measurable change for our clients and for healthcare professional and patients around the world.

We’ve talked about Delivering Change as part of the CHC brand for a couple of years now and even before that, it was a founding principle of the company.

Read more

We have launched our new planning model for Delivering Change

Those of you who are familiar with CHC might recognise our core values of Building Collaboration, Inspiring Confidence and Delivering Change. After over a year’s worth of valuable qualitative and quantitative research into the ever-evolving needs of those working in pharmaceutical marketing, medical and communications functions, we are thrilled to be launching our new Delivering ChangeTM planning model.
Read more

Patient-Pharma interactions; a mutually beneficial relationship?

Patient-Pharma interactions are vital for drug development, but are often seen in a negative light. There will always be sceptics; those who think pharma companies have cynical intentions when approaching patients, and conversely, those who feel some patients advocate for the wrong motives. However, in recent years patient advocacy has become a pivotal aspect of the drug development process, where pharma companies have increasingly sought the unique insight that patients can offer.

So can there be a healthy and mutually beneficial relationship between patients and pharmaceutical companies? Read more

Exciting advances of digital technology in healthcare

At CHC we like to keep our ear to the ground, we also like to stay ahead of the curve when it comes to innovation within healthcare. With this in mind, I recently attended an event called ‘The Future of Digital Healthcare’. Run by DSMLF in collaboration with Bupa, it was a day packed with interesting presentations and discussions about the role digital technology has within healthcare. Read more

CHANGE

So the team told me I had to write the first post on our new CHC blog, Can’t Help Commenting.  As someone who has quite a few opinions (just ask my colleagues and clients!) on communications and the critical role it can and should play in health and medicine I’ve actually found it pretty difficult to nail down a single topic.  Perhaps this bodes well for the start of a blog – there should be no excuses if the blogs ‘dry up’.

But a few meetings and conversations in the last week or so have helped me arrive on a topic.  Change.  And how much what we do has changed in the last few years. Read more